Sumant Inamdar is a Gastroenterology physician affiliated with University of Arkansas at Little Rock. OpenAlex indexes 313 publications with 6,049 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 W Markham St # 753
Little Rock, AR 722057101
Telephone
501-686-8000Provider last certified this registry record 17 Mar 2020.
Clinical trials
- Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial
Sponsor: University of Arkansas
- Comparing the Franseen and Fork-top Needles for EUS-guided Fine-needle Biopsy of Solid Mass Lesions.
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20255 payments
- CONMED CorporationProgram year20251 payment
- Olympus America Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.1%Proton pump inhibitor55.2%Pantoprazole Sodium54%Omeprazole46%Part D<11 patientsAluminum Complex29.9%Sucralfate100%Part D<11 patientsAnti-infectives
14.9%Fluoroquinolone Antibacterial14.9%Levofloxacin100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
The Lancet. Gastroenterology & hepatology
2024 - Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis
Gastrointestinal Endoscopy
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Suen, MD
University of Arkansas at Little Rock
Jamie Cannon, MD
University of Arkansas at Little Rock
Kricia Palmer, MD
University of Arkansas at Little Rock
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”